✦ LIBER ✦

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

✍ Scribed by S. Forrest Dodson; Michael E. de Vera; C. Andrew Bonham; David A. Geller; Jorge Rakela; John J. Fung

Book ID: 111722907
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 57 KB
Volume: 6
Category: Article
ISSN: 1527-6465
DOI: 10.1053/jlts.2000.6446

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from intravenous to intramusc

Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation

✍ Steven-Huy Han; Paul Martin; Marc Edelstein; Rena Hu; Gregg Kunder; Curtis Holt; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Intramuscular hepatitis B immune globuli

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

✍ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Subcutaneous hepatitis B immune globulin

Subcutaneous hepatitis B immune globulin after liver transplantation

✍ Eric M. Yoshida; Nilu Partovi; Erica D. Greanya 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

An efficacy and cost-effectiveness analy

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

✍ Steven-Huy B. Han; Joshua Ofman; Curtis Holt; Kevin King; Gregg Kunder; Pauline 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Hepatitis B immunoglobulins and/or lamiv

Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic review

✍ Jie Chen; Liping Yi; Ji Dong Jia; Hong Ma; Hong You 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Prophylaxis against hepatitis B recurren

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

✍ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA